Código QR (código de barras bidimensional)

Tolvaptan Improves Refractory Ascites and Overall Survival in Cirrhosis: A Meta-Analysis

Introduction: Refractory ascites is a frequent complication associated with liver cirrhosis. Tolvaptan, a V2-receptor antagonist, has shown effectiveness in improving refractory ascites. This meta-analysis sought to assess the effectiveness of tolvaptan in patients suffering from cirrhosis and refra...

ver descrição completa

Na minha lista:
Principais autores: Chetan Kalal, Harshad Joshi, Shankar Zanwar, Madhumita Premkumar
Formato: Artigo
Idioma:Inglês
Publicado em: Faculty of Medicine, Universitas Airlangga 2025-01-01
coleção:Current Internal Medicine Research and Practice Surabaya Journal
Assuntos:
cirrhosis
overall survival
refractory ascites
tolvaptan
human & health
Acesso em linha:https://e-journal.unair.ac.id/CIMRJ/article/view/60741
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados